Antipodes Partners’s Cigna CI Stock Holding History

Antipodes Partners’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.2K	Buy	+124	New	+$35K	﹤0.01%	123

Other funds holding CI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Antipodes Partners's CI Position: Q2 2026 in Review

Antipodes Partners opened a new position in Cigna (CI) in Q2 2026: 124 shares worth $34.2K. The stake represents ﹤0.01% of the portfolio and ranks #123 among its holdings.

1,692 funds tracked by Wall St. Rank hold CI as of Q2 2026.

Antipodes Partners held 124 shares of Cigna worth $34.2K as of Q2 2026.
Cigna was a new Antipodes Partners position in Q2 2026.
Cigna made up ﹤0.01% of Antipodes Partners's portfolio in Q2 2026, its #123 holding.
1,692 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.